The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Articles
Search our media releases, news, safety updates (medicines and medical devices), vaccine safety reports, and notices.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Safety (17)
- Medicine safety (85)
- Medical devices safety (20)
- Prescription medicines (12)
- Alert/Advisory (8)
- COVID-19 vaccines (4)
- Non-prescription medicines (2)
- Over the counter (OTC) medicines (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Labelling and packaging (1)
- Listed medicines (1)
- Registered complementary medicines (1)
- Therapeutic goods regulation (1)
Search
17 result(s) found, displaying 1 to 17
-
Safety updatesMore prominent warnings are being added to the product information (PI) and consumer medicine information (CMI) for all oral and injectable (systemic) fluoroquinolones to strengthen existing warnings about serious side effects
-
Safety updatesThere may be an increased risk of neurodevelopmental disorders in children born to men who have taken sodium valproate in the 3 months before conception.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesAdditional safety information is being added to all montelukast products to strengthen and highlight existing warnings about serious neuropsychiatric events.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesHealth professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
-
Safety updatesWe have received Australian reports of Guillain-Barré Syndrome (GBS) following Shingrix vaccination.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesThe Product Information documents for antidepressants have been updated with warnings about sexual dysfunction continuing in some patients, after they stop using the medicines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesA warning about anticoagulant-related nephropathy (ARN) has been added to the Product Information (PI) for all oral anticoagulants.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Safety updatesHealth professionals should check if patients undergoing general anaesthesia have used products containing pholcodine in the previous 12 months.
-
-
Safety updatesIn this issue: Action after registry data analysis; Environmental extremes; Button battery dangers; Infant sleep positioners reviewed